This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
However, a major bottleneck for the healthtech industry is the inability to sell effectively into the healthcare provider and plan markets. digital health, medical device, and biotech companies) to sell more effectively and efficiently to healthcare providers (eg. physicians, physician groups, hospitals, health systems, etc).
Co-founded by industry leaders Luis Voloch, Mark Jacobstein, and Sahil Sudeach with a background in AI, healthcare, and biotechnologyJimini Health brings together expertise from healthcare and technology to create an evidence-backed, clinician-led mental health model.
MDisrupt was founded by Gadelrab, a seasoned health tech executive who has successfully commercialized healthcare and life sciences, served on the executive team at 23andMe, and advised many leading companies in the biotech and genetics sectors. MDisrupt has raised $6.6
Innovative startups in the health IT, medical device, and biotech fields were among the shining stars at the annual Collision conference. Healthcare IT Today had the opportunity to catch up with several interesting company leaders including Dolma Tsundu from Flutter Care , Eunice Wu from Asepha , and Marc Paderon from Pontosense.
Reflecting on AION Lab’s role in nurturing biotech startups, Gill underscores the company’s commitment to fostering innovation and supporting the growth of emerging ventures. Check our our video interview below to learn more about AION Labs approach to innovation in pharma and life sciences. Tell us what you think.
Driven by advancements in technology, the increasing prevalence of chronic diseases, and rising healthcare costs, the personalized medicine market is expected to surpass $1.2 Simultaneously, generative AI has emerged as a transformative tool within healthcare, promising better patient outcomes and operational efficiencies for clinicians.
The landscape of healthcare and biotechnology is changing at a rapid pace, with data taking center stage. The primary use cases for cognitive AI in biotech include accelerating data analysis, automating document management, improving collaboration, and reducing risk of human error.
Affineon integrates seamlessly with EHR systems, saving providers time and enhancing the healthcare experience. About the Investors GPG Ventures is a Texas-based healthcare VC firm. With offices in Dallas, Houston, and Austin, GPG Ventures invests nationally in biotech, digital health, medtech, consumer health, and general B2B tech.
Dell Technologies has developed a suite of digital twin solutions that are specifically designed to accelerate the biotech development process at every stage with patient digital twins. About Steve Lazer Steve is the Global Healthcare and Life Sciences CTO for Dell Technologies.
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients.
The round was led by Eventide Asset Management (Eventide), which invests in biotech and life science healthcare companies seeking solutions for unmet clinical needs. million in Series B funding, bringing its total funding to date to $31.5
Bonfire Analytics is a company that enables digital health, medical device, and biotech organizations to identify qualified leads through machine learning and analytics. The company was recently founded in 2022 and has achieved tangible success for both itself and its clients.
Last night, I watched a video about the rise and fall of disgraced biotech startup Theranos, which claimed to have invented technology that would dramatically change clinical blood testing worked.
We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. I anticipate that smaller biotech companies will consider multiple avenues for securing funding, including through SPAC deals similar to the one that we at Abpro announced this year.
These figures highlight its ability to grow profitably, a rarity in healthcare IT, and its dominance in the digital physician market, which it expects to expand 5-7% annually, with Doximity aiming to outpace that. Comparatively, the healthcare sector has lagged in recent years, but 2025 is showing signs of a turnaround.
Richard Baron, CEO of the American Board of Internal Medicine, who wrote in the American Journal of Accountable Care , “Rebuilding trust within our healthcare system and nurturing an ecosystem in which trust is a core operating principle requires a more comprehensive and sustained effort. The post Healthcare, Heal Thyself!
Unlearn partners with pharma sponsors, biotech companies, and academic institutions to streamline and optimize clinical trials, enabling researchers to assess the safety and efficacy of new treatments more quickly and accurately.
“This investment provides us with the resources to further advance our platform and expand our reach to additional pharma, CRO, and biotech companies in Europe and the U.S., Raviv Pryluk, Co-Founder and CEO at PhaseV. bringing new needed treatments to patients.”
Welcome to the weekly edition of Healthcare IT Today Bonus Features. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.
Hood Medicine & PathCheck Foundation recently participated in a panel discussion on digital vaccines with Bhargav Sri Prakash , Founder & CEO of FriendsLearn , a biotech firm that pioneered the technology.
Welcome to the weekly edition of Healthcare IT Today Bonus Features. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.
Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a look back at the articles we posted and why they’re important to the healthcare IT community. We asked the Healthcare IT Today community to discuss TEFCA’s role in interoperability. TEFCA’s Role in Facilitating Seamless Data Sharing.
Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. Healthcare IT companies: 3.5x Smaller, unprofitable startups may see compression (3-4x) unless they prove profitability or secure strategic buyers. This is down from 6.5x
To help navigate these efforts, the company has added Dr. Sharon Shacham, a serial biotech entrepreneur and Founder of Karyopharm Therapeutics, to Protai’s Board of Directors. In addition, Protai is supported by leading oncology experts, including Prof.
Welcome to the special HLTH 2023 edition of Healthcare IT Today Bonus Features. RedHealthy Communications : PR and marketing for biotech, life sciences, and digital health. If you have news that you’d like us to consider for a future edition of Healthcare IT Today Bonus Features , please submit them on this page.
Parker Health an innovative biotech company for electronic health records, hospital developer & management, and subscription-based health services, today announced that it has secured $25 million in Series A funding led by Bias Capital, a multisector and multi-stage angel syndicate, joined in this round by L’PAJ Ventures, CGT Capital Group, and (..)
Welcome to the weekly edition of Healthcare IT Today Bonus Features. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.
This growth is expected to create opportunities for M&A activity, as pharmaceutical companies look to acquire smaller, innovative biotech companies. Consolidation of the healthcare industry: The healthcare industry is consolidating, as larger companies acquire smaller ones in order to gain market share and scale.
New research has found that healthcare organizations around the world have big plans for digital transformation but often stumble when it comes to implementing this process.
Even as venture capital in healthcare languishes, we see bright spots specific to the growing intersection of biotech and computation. Larry Ellison, Oracle co-founder and CEO, went on record during an acquisition presentation last summer about healthcare’s data shortcomings and the need to address them.
Here are some examples of Scotland's global reach in digital health and care: NHS Scotland's national digital health record: This record stores patient information electronically, making it accessible to healthcare professionals across the country. This has improved patient care and reduced duplication of services.
Over the next five years, healthcare and life sciences firms will ramp up their digital transformation efforts, driven at least in part by AI and data analytics tools, according to a recent research report. In fact AI, in particular, should revolutionize the nature of work in one in three health systems within a few years, […].
and the Chinese Communist Party (CCP) and House Select Subcommittee on the Coronavirus Pandemic, the BIOSECURE Act is intended to control the biotech supply chain and secure citizens’ genetic data. Where the BIOSECURE Act Falls Short According to the House Select Committee on the Strategic Competition Between the U.S.
This same process is now being done at the individual and family basis through a distributed biotech model. As we saw with COVID, when treatments were needed more rapidly than the typical drug development timeline could offer, we identified existing medicines that could be repurposed (such as remdesevir and dexamethasone, among many others.)
A New Era for AI-Enabled Bioinformatics The biotech and bioinformatics landscape is rapidly evolving, driven in part by technological advances in AI. About Seqera Seqera is the driving force behind Nextflow, MultiQC, and the Seqera Platform – the modern biotech stack. Stay tuned!
We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. The new year will bear witness to great innovation in biotech in the precision oncology space. Dr. Ofer Sharon, CEO at OncoHost.
She has been involved with more than 20 early-stage biotech and healthcare startups, including ones working on medical devices and digital health. She has written four books, including The Patient as CEO: How Technology Empowers the Healthcare Consumer and, most recently, How AI Can Democratize Healthcare: The Rise in Digital Care.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
124 
Let's personalize your content